本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Pasithea Therapeutics Corp.

0.7322
-0.0156-2.09%
盘后0.7200-0.0122-1.67%16:53 EDT
成交量:6.71万
成交额:4.99万
市值:545.02万
市盈率:-0.07
高:0.7650
开:0.7254
低:0.7250
收:0.7478
数据加载中...
2023/03/10

重要事件披露

8-K - Current report
2023/02/15

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/01/24

重要事件披露

8-K - Current report
2023/01/13

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/01/10

超过5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2022/12/14

重要事件披露

8-K - Current report
2022/12/14

超过5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2022/11/14

SEC问询函

CORRESP [Cover] - Correspondence
2022/11/14

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2022/11/01

超过5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2022/10/20

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2022/10/12

重要事件披露

8-K - Current report
2022/09/21

员工持股计划

S-8 - Securities to be offered to employees in employee benefit plans
2022/09/20

重要事件披露

8-K - Current report
2022/09/06

超过5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2022/09/01

超过5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2022/08/29

重要事件披露

8-K/A [Amend] - Current report
2022/08/15

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2022/08/11

超过5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2022/07/28

超过5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership